The present invention provides a method of effectively measuring risk for therapeutic toxicity of a subject having an autoimmune disorder or cancer and predicting and evaluating therapeutic efficacy of immunosuppressive therapies for autoimmune diseases and cancers before or after starting therapy. The present invention also provides for determining a drug metabolite level of a subject during therapy and measuring periodically the drug metabolite level of a subject on maintenance therapy to ensure treatment compliance and continued therapeutic response by measuring minimal clinical important differences (MCID) in the drug metabolite levels. The present invention also provides for a method to effectively optimize the selection and dose of immunosuppressive therapies of a subject having an autoimmune disease or cancer to improve therapeutic efficacy and reduce therapeutic toxicity prior to starting concomitant biologic therapy and before or after the subject has failed to respond to the at least one immunosuppressive agent.
Composition And Method To Optimize And Customize Nutritional Supplement Formulations By Measuring Genetic And Metabolomic Contributing Factors To Disease Diagnosis, Stratification, Prognosis, Metabolism, And Therapeutic Outcomes
The present invention relates to a composition and custom business model and methods to measure genetic and metabolomic contributing factors affecting disease diagnosis, stratification, and prognosis, as well as the metabolism, efficacy and/or toxicity associated with specific vitamins, minerals, herbal supplements, homeopathic ingredients, and other ingredients for the purposes of customizing a subject's nutritional supplements with custom formulations to optimize health outcomes.
Howard County Public Schools since Dec 2010
Vice Chairman, Board of Education of Howard County
Proove Biosciences, Inc. - Los Angeles, CA since Dec 2009
Founder and President
Meshkin Ventures Jan 2008 - Jun 2011
Independent Consultant and Investor
Howard Community College Aug 2009 - Aug 2010
Adjunct Professor of Entrepreneurship
Salugen, Inc. - San Diego, California Apr 2005 - Jul 2009
President and CEO
Education:
University of Maryland College Park 1995 - 1997
Bachelors, Government & Politics and General Business
Glenelg High School 1990 - 1994
Skills:
Entrepreneurship Strategic Planning Leadership Strategy Cross Functional Team Leadership Marketing Strategy Marketing Management Biotechnology Community Outreach Healthcare Sales Consulting Leadership Development Team Building Pharmaceutical Industry Product Management Fundraising Social Entrepreneurship Executive Management Start Ups Medical Devices Corporate Development Personalized Medicine Strategic Thinking Management Consulting Instructional Technology Selling Commercialization Educational Leadership Cancer Medical Diagnostics Innovation Strategic Partnerships Lifesciences Business Planning Pharmacogenetics Molecular Genetics Angel Investing Corporate Venture Capital Senior Executive Leadership Technological Innovation Business Innovation Organizational Development Small Business Infectious Diseases Competitive Analysis Education Policy Ebusiness Suite Digital Education
Interests:
Experiencing Life With My Family Coaching and Playing Sports Tweetdeck Volunteering For Good Causes Politics Seeing the World Through My Kids' Eyes Web Marketing Problem Solving Hootsuite American Red Cross (National Society) The Washington Post Reforming Public Policy Gifts Beowulf Open Government Glenn Beck